1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Epsilogen Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha MOv18 IgE - Advanced Ovarian Cancer, Platinum-resistant Ovarian Cancer | Phase 1 | Recruiting | Epsilogen Ltd | 45 | 2024-09-03 | 2026-04-06 |
Endometrial Neoplasms (1) · Neoplasms (1) · Triple Negative Breast Neoplasms (1)
United Kingdom (1)